Your browser doesn't support javascript.
loading
Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial.
Cameron, David; Brown, Julia; Dent, Rebecca; Jackisch, Christian; Mackey, John; Pivot, Xavier; Steger, Guenther G; Suter, Thomas M; Toi, Masakazu; Parmar, Mahesh; Laeufle, Rita; Im, Young-Hyuck; Romieu, Gilles; Harvey, Vernon; Lipatov, Oleg; Pienkowski, Tadeusz; Cottu, Paul; Chan, Arlene; Im, Seock-Ah; Hall, Peter S; Bubuteishvili-Pacaud, Lida; Henschel, Volkmar; Deurloo, Regula J; Pallaud, Celine; Bell, Richard.
Affiliation
  • Cameron D; University of Edinburgh and Cancer Services, NHS Lothian, Edinburgh, UK. d.cameron@ed.ac.uk
Lancet Oncol ; 14(10): 933-42, 2013 Sep.
Article in En | MEDLINE | ID: mdl-23932548
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Vascular Endothelial Growth Factor A / Antibodies, Monoclonal, Humanized Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2013 Type: Article Affiliation country: United kingdom
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Vascular Endothelial Growth Factor A / Antibodies, Monoclonal, Humanized Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2013 Type: Article Affiliation country: United kingdom